机构:[1]Department of Neurosurgery, The First Medical Center of Chinese People’s Liberation Army General Hospital, Beijing 100853, P.R. China[2]Department of Radiotherapy, Beijing Tiantan Hospital, Capital Medical University, Beijing 10070, P.R. China首都医科大学附属天坛医院[3]Key Laboratory of Chinese Medicinal Resource from Lingnan, Ministry of Education, Guangzhou University of Chinese Medicine, Guangzhou 510006, P.R. China[4]School of Basic Medical Science, Capital Medical University, Beijing 100069, P.R. China[5]Medical Laboratory Center, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, P.R. China[6]Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen 518000, P.R. China深圳市南山区人民医院深圳医学信息中心[7]Department of Pathology, The First Medical Center of Chinese People’s Liberation Army General Hospital, Beijing 100853, P.R. China[8]Langhorne, Bucks County, PA 19047, US[9]School of Pharmaceutical Sciences, Temple University, Philadelphia, PA 19140, USA[10]Department of Neuro-Pathology, Sanbo Brain Hospital, Capital Medical University, Beijing 100093, P. R. China[11]Department of Neuro-Oncology, Sanbo Brain Hospital, Capital Medical University, Beijing 100093, P.R. China[12]Department of Neurosurgery, Beijing Electric Power Hospital, Beijing 100073, P.R. China[13]State Key Laboratory of Molecular Oncology, Chinese Academy of Medical Science Cancer Hospital/National Cancer Center, Beijing 100021, P.R. China[14]Department of Neurosurgery,The Affiliated Hospital of Hebei University,Baoding 122311,P.R. China河北大学附属医院重点学科神经外科
National Natural
Science Foundation of China (81902975 to H.L. and 81871087 and
1716312-zt-00600303 to X.Y.), the National Key Research and Development
Program of China (2018YFC1002500 to X.Y.), the 65th China Postdoctoral
Science Foundation (2019M653940 to H.L.), the Medical Big Data Research
Program of Chinese PLA General Hospital (2018MBD-20 to S.F.), and by the
Clinical Research Support Program of Chinese PLA General Hospital
(2016FCCXYY2010 to S.F.).
第一作者机构:[1]Department of Neurosurgery, The First Medical Center of Chinese People’s Liberation Army General Hospital, Beijing 100853, P.R. China[2]Department of Radiotherapy, Beijing Tiantan Hospital, Capital Medical University, Beijing 10070, P.R. China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Hailong Liu,Youliang Sun,Qian Zhang,et al.Pro-inflammatory and proliferative microglia drive progression of glioblastoma.[J].CELL REPORTS.2021,36(11):109718.doi:10.1016/j.celrep.2021.109718.
APA:
Hailong Liu,Youliang Sun,Qian Zhang,Wei Jin,Renata E. Gordon...&Shiyu Feng.(2021).Pro-inflammatory and proliferative microglia drive progression of glioblastoma..CELL REPORTS,36,(11)
MLA:
Hailong Liu,et al."Pro-inflammatory and proliferative microglia drive progression of glioblastoma.".CELL REPORTS 36..11(2021):109718